A new research centre, which will be focusing on psychedelics exclusively, has been launched at the prestigious John Hopkins University.
The centre will focus on identifying therapies derived from psychedelics for diseases like PTSD, addiction and Alzheimer’s.
A group of private investors - from Silicon Valley - has given $17 million to start the Center for Psychedelic and Consciousness Research at the university, which is believed to be the first such research center in the U.S. and the largest research center of its kind in the world.
The studies will also determine psychedelics’ effectiveness as possible therapies for opoid addiction, chronic Lyme disease and anorexia nervosa.